This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

James L. Claghorn, MD; Joseph C. Schoolar, PhD, MD

JAMA. 1966;196(12):1089-1091.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MOST DRUGS which relieve pain or exert a sedative effect on the central nervous system are subject to abuse, even though they do not cause rapid tolerance development or withdrawal symptoms. Propoxyphene hydrochloride appears to occupy an intermediate position between this group and the narcotic drugs proper. While there is, as yet, no large social problem with propoxyphene abuse, the possibility may well exist.

Propoxyphene is a frequently used analgesic chemically similar to meperidine hydrochloride, methadone hydrochloride, and alphaprodine hydrochloride. This drug, regarded as presenting a minimal addiction liability by the expert committee of the World Health Organization¹ and not subject to control domestically, was first shown to produce physical dependence by Fraser and Isbell in 1960.² Euphoria is reported by some patients. Among 14 patients in a double-blind comparison of placebo, codeine, propoxyphene and aspirin, propoxyphene was selected most often as being a euphoriant, and its frequency . . . [Full Text PDF of this Article]

Author Affiliations
From the Houston State Psychiatric Institute, and Baylor University College of Medicine, Houston.

Footnotes
Reprint requests to 1300 Moursund Ave, Houston 77025 (Dr. Claghorn).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?